每年出版 6 期
ISSN 打印: 1045-4403
ISSN 在线: 2162-6502
Indexed in
lep Expression and Its Role in Obesity and Type-2 Diabetes
摘要
Obesity is metabolic disorder that increases the risk of diabetes, heart disease, and other metabolic syndromes in human beings. One sign of diabetes is increased blood glucose levels in the body. Glucose levels increase due to problems with insulin secretion or insulin resistance. Maturity onset of diabetes of the young is more common in adults and occurs due to insulin resistance. Both diabetes and obesity are major problems that are responsible for the death of millions of individuals every year, worldwide. Leptin, a 164-KDa hormone that is secreted by white adipose tissue, is a product of the lep gene. Mutation in lep decreases leptin concentration and increases obesity and type-2 diabetes mellitus. Leptin has been shown to produce positive effects on hunger, energy expenditure, and behavior and is thus useful in the treatment of obesity and type-2 diabetes. Leptin controls appetite through its effect on the hypothalamus in the brain. Both leptin and insulin regulate appetite, body weight, and glucose levels in the body.
-
Kahl Kai G., Stapel Britta, Frieling Helge, Link between depression and cardiovascular diseases due to epigenomics and proteomics: Focus on energy metabolism, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 89, 2019. Crossref
-
Liu Wei, Zhou Xianghai, Li Yufeng, Zhang Simin, Cai Xiaoling, Zhang Rui, Gong Siqian, Han Xueyao, Ji Linong, Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus, Medicine, 99, 6, 2020. Crossref
-
Noreen Zarish, Loffredo Christopher A., Bhatti Attya, Simhadri Jyothirmai J., Nunlee-Bland Gail, Nnanabu Thomas, John Peter, Khan Jahangir S., Ghosh Somiranjan, Transcriptional Profiling and Biological Pathway(s) Analysis of Type 2 Diabetes Mellitus in a Pakistani Population, International Journal of Environmental Research and Public Health, 17, 16, 2020. Crossref
-
El Bitar Fadia, Al Sudairy Nourah, Qadi Najeeb, Al Rajeh Saad, Alghamdi Fatimah, Al Amari Hala, Al Dawsari Ghadeer, Alsubaie Sahar, Al Sudairi Mishael, Abdulaziz Sara, Al Tassan Nada, A Comprehensive Analysis of Unique and Recurrent Copy Number Variations in Alzheimer’s Disease and its Related Disorders, Current Alzheimer Research, 17, 10, 2021. Crossref
-
Sorokina Yu. A., Zanozina O. V., Makarova E. V., Salcev S. G., Varvarina G. N., Lovtsova L. V., Leptin and its receptor gene polymorphism as a target for pharmacotherapy in T2DM and COPD, Meditsinskiy sovet = Medical Council, 7, 2021. Crossref
-
Yoldemir Sengul Aydin, Arman Yucel, Akarsu Murat, Altun Ozgur, Ozcan Mustafa, Tukek Tufan, Correlation of glycemic regulation and endotrophin in patients with type 2 Diabetes; pilot study, Diabetology & Metabolic Syndrome, 13, 1, 2021. Crossref
-
Mir Mohammad Muzaffar, Mir Rashid, Alghamdi Mushabab Ayed Abdullah, Wani Javed Iqbal, Sabah Zia Ul, Jeelani Mohammed, Marakala Vijaya, Sohail Shahzada Khalid, O’haj Mohamed, Alharthi Muffarah Hamid, Alamri Mohannad Mohammad S., Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study, Journal of Personalized Medicine, 12, 5, 2022. Crossref
-
Wang Yunzhe, Zhang Chenyang, Wang Yuxiang, Liu Xiuping, Zhang Zhao, Enhancer RNA (eRNA) in Human Diseases, International Journal of Molecular Sciences, 23, 19, 2022. Crossref